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Expression and immunogenicity of HLA-B27 in high-
transfection recipient P815: a new method to induce 
monoclonal antibodies directed against HLA-B27 
S. R . T H U R A U * , G . W I L D N E R § , W . K U O N , E . H . W E I S S and G . R I E T H M Ü L L E R 
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The immunization of a (BALB/c x C57BL/6) Fi mouse with murine transfectants 
expressing the HLA-B27 antigen resulted in a panel of polymorphic monoclonal 
antibodies with specificity for HLA-B27 and some additional HLA-antigens. Speci-
ficity of the antibodies was defined by cytofluorometric analysis on a panel of 
lymphoblastoid cell lines (LCL) derived from HLA typed individuals. Three of 
these antibodies are cytotoxic, and one of them inhibits B27-specific T cell cytotox-
icity. Our results indicate that HLA-class I transfectants could be used to generate 
polymorphic antibodies, and that these antibodies may be helpful for HLA typing 
and for definition of epitopes recognized by T cells. 
Received for publication 27 September, revised, accepted 2 December 1988 
The transfection of isolated genes into recip-
ient cells offers a new way to study the expres-
sion and biological function of the gene prod-
ucts isolated from their normal environment 
(Heyes et al. 1986, Barbosa et al. 1984, Ma-
ryanski et al. 1985, Cowan et al. 1985, Go-
mard et al. 1986, Herman et al. 1983, Mentzer 
et al. 1986, van de Rijn et al. 1984). Owing to 
its high association to rheumatoid diseases 
such as ankylosing spondylitis and Reiter's 
syndrome (Tiwari & Terasaki 1985, Terasaki 
1980), high interest focuses on the HLA-B27 
antigen. The gene has been isolated, se-
quenced (Weiss et al. 1985, Szöts et al. 1986) 
and transfected into the mouse mastocytoma 
line P815. Serological assays demonstrated 
that these transfectants express functional 
B27 antigens (W.K. , unpublished observa-
tion). 
These transfectants were used as immuno-
gens to generate specific monoclonal antibod-
ies. After immunization of mice with one high 
expressing transfectant clone, established 
with an in vitro mutated HLA-B27 gene, four 
monoclonal antibodies were isolated with 
specificity for B27 and additional H L A anti-
gens (such as B8, B13, B15, B18, B37 and 
B44), according to indirect immunofluores-
cence analysis. One monoclonal antibody rec-
ognized all tested cells expressing HLA-class I 
33 Tissue Antigens 33:5 
512 THURAU E T AL. 
antigens. Three of these antibodies show com-
plement dependent cytolysis, and therefore 
may be useful reagents for H L A typing. One 
of the monoclonal antibodies also inhibits B27 
specific T cell cytotoxicity. 
Material and Methods 
Transfection of the mutated and unmutated 
HLA-B27 genes 
The cosmid clone cd2.6 encoding HLA-B27 W 
(Weiss et al. 1985, Szöts et al. 1986) or a 6.5 
kilobase Eco R I subclone (Kuon et al. 1986) 
were transfected into the mouse mastocytoma 
line P815 (Weiss et al. 1985, Van Pel et al. 
1985). The Eco R I subclone contained a mu-
tated B27 gene, generated in vitro by site di-
rected mutagenesis, exchanging serine at posi-
tion 131 to arginine. The transfection of the 
unmutated B27 w gene resulted in a transfec-
tant clone designated B27.3, whereas trans-
fectant clone B27.R3 expressed the mutated 
gene. After recloning, the transfectants were 
tested on a panel of monoclonal antibodies to 
control surface expression and specificity of 
the introduced H L A genes. 
Immunization and fusion 
A ( B A L B / c x C57BL/6) F i mouse was immu-
nized with the P815 (DBA/2) transfectant 
B27.R3 expressing the mutated B27 antigen 
with an amino acid exchange at position 131 
from serine to arginine. 7 x 106 B27.R3 cells 
were injected intra-peritoneally together with 
108 Bordetella pertussis (Behring Institut, 
Marburg), followed by a second injection with 
1.2 x 107 B27.R3 cells and 108 B . pert, on day 
59. Three days later the spleen cells were 
fused with the mouse myeloma X63Ag8.653 
(Kearney et al. 1979, Galfre et al. 1977). 
Cells were grown in RPMI 1640 medium 
supplemented with 5% fetal calf serum (FCS, 
Sebio, Boehringer) or 5% Clex (Falcon), 2 
mM L-glutamine, 100 I U penicillin/ml, 100 u.g 
streptomycin/ml, 20 pM 2-mercaptoethanol, 1 
mM sodiumpyruvate and 1 mM non-essential 
amino acids at 37°C in a humidity-saturated 
atmosphere with 5% CO2. 
Supernatants were screened in an indirect 
immunofluorescence assay on a homozygous 
B27 w L C L (LG-2 , Gatti & Leibold 1979) and 
the HLA-class I surface negative cell line 
Daudi (Ploegh et al. 1979). Positive hybrid-
omas were cloned by limiting dilution before 
expansion. 
Indirect immunofluorescence assay 
Cells were pelleted in round bottom microti-
terplates and incubated with antibody con-
taining culture supernatant for 1 h. After 
washing with phosphate buffered saline 
(PBS), cells were stained with FITC-coupled 
goat anti mouse IgG & IgM (Dianova, Ham-
burg) for 30 min, washed, fixed with 1% par-
aformaldehyde and analyzed by fluorescence-
microscopy or by cytofluorography ( E P I C S 
V , Coulter or FACScan, Becton and Dickin-
son). All steps were carried out on ice. 
Complement dependent 
microlymphocytotoxicity assay 
Complement dependent cytotoxicity of mono-
clonal antibodies was tested in a two-stage 
microlymphocytotoxicity assay on peripheral 
blood lymphocytes (PBL) according to Tera-
saki & McClelland (1964). For cytolysis we 
used rabbit complement obtained from Behr-
ing Institute, Marburg. Lympholysis in per-
cent was calculated for a 1:10 dilution of su-
pernatants. Lymphocytotoxicity was regarded 
as positive when at least 40% of cells were 
lysed. 
Inhibition of cell mediated 
lymphocytotoxicity (CML) 
P B L of donor MIWI (A2, B17, B51, C w l , 
Cw6) were stimulated with P B L of donor 
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Figure 1. EPICS analysis: HLA-B27 surface antigen 
expression of P815 transfection clones (top: unmu-
tated gene B27.3; bottom: mutated B27 gene 
B27.R3), determined by monoclonal antibody ME1 
(specific for HLA-B27, -B7, -B22) (Ellis et al. 
1982). Results are plotted as cell number (y-axis) 
versus log fluorescence intensity (x-axis). 
H A S E (A2, A3, B27 w , B37, C w l ) as de-
scribed elsewhere (Sehende! et al. 1978, 
Wildner et al. 1988). After 6 days, B27-specif-
ic cytotoxicity was tested in a 4 h chromium 
release assay on 5 1 C r labeled L C L L G - 2 (A2, 
B27 w , Cwl ) in 200 pi of culture medium con-
taining hybridoma supernatants of varying di-
lutions. Chromium release was measured and 
calculated as described by Schendel et al. 
(1978). 
For secondary response, cytotoxic T lym-
phocytes ( C T L ) were maintained for 21 days 
with IL-2 but without further antigenic stim-
ulation. In this case the chromium release as-
say was performed at the effector:target ratio 
of 5:1. 
Results 
Characterization of transfectants 
Fluorescence profiles (Figure 1) show that 
both transfectants B27.3 and B27.R3 are rec-
ognized by antibody ME1 (Ellis et al. 1982), 
which is specific for B7, B22 and B27. This 
pattern was confirmed by the monoclonal an-
tibodies W6/32 (Barnstable et al. 1978), 
B27M1 (Grumet et al. 1981) and B27M2 
(Grumet et al. 1982), whereas non-related an-
tibodies did not bind to the transfectants (data 
not shown). Figure 1 also shows that the 
B27.R3 transfectant P815 clone with the mu-
tated HLA-B27 gene expressed an increased 
amount of surface HLA-B27 antigen com-
pared to the transfectant B27.3 containing the 
unmutated form. Transfectant B27.R3 was se-
lected for immunization because of its clonal 
stability and increased expression of B27-sur-
face antigen. 
HLA specificity of generated antibodies 
1010 hybridoma supernatants from two fusion 
experiments with the spleen cells of one single 
mouse were screened on a small informative 
panel of L C L with B27 positive and B27 nega-
tive cells. Five of them were selected for fur-
ther investigation and tested on a panel of 62 
B-cell lines from unrelated, HLA-typed do-
nors. The correlation between H L A antigens 
and monoclonal antibody reactivities was 
evaluated by the coefficient of correlation (r) 
computed from 2 x 2 tables, and significance 
(P) evaluated with a X 2 test (Simons & Tait 
1984). The results are shown in Table 1. 
The monoclonal antibodies TM-1, TM-4, 
TM-5 and TM-6 all recognize B27 + cells and 
show crossreactivity to other H L A - B , but not 
to H L A - A , - C or class II antigens. Antibody 
33* 
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Table 1. 
Cytofluorometry. Reactivity and r values of TM-1, TM-3, TM-4, TM-5 and TM-6 on unrelated B cell lines. 
Antibody Recognized antigens No. of cells No. of cells x° Pa Total No. 
tested reactive of cells 
with anti- tested with 
body antibody* 
TM-1 B27 9 9 0.67 0.001 61 
B44 17 13 0.60 0.001 61 
B15 3 3 0.56 0.001 61 
B27, B44, B15 28 24 0.68 0.001 61 
TM-3 HLA-class I (monomorphic) 59 59 1.0 0.001 59 
TM-4 B27 w 10 9 0.87 0.001 62 
B15 1 1 1.00 n.s. 62 
B27w, B15 11 10 0.84 0.001 62 
TM-5 B13 3 3 0.54 0.001 62 
B27 8 8 0.70 0.001 62 
B37 2 2 0.43 0.001 62 
B15 3 3 0.58 0.001 62 
B13, B27, B15, B37 18 17 0.76 0.001 62 
TM-6 B15 5 4 0.50 0.05 60 
B44 14 13 0.69 0.001 60 
B27 8 7 0.61 0.001 60 
B8 6 5 0.55 0.025 60 
B18 4 3 0.50 0.05 60 
B15, B44, B27, B8, B18 38 32 0.66 0.001 60 
a For calculation of r (coefficient of correlation) and P (probability), the other HLA antigens indicated in 
this table were excluded. 
b Total number of tested cells, bearing 17 different HLA-A, 31 different HLA-B and eight different HLA-C 
antigens, 
n.s. not significant. 
TM-1 also bound to 76% of the B44 + and 37% 
of the B15 + cells. Exon shuffling experiments 
with hybrids of B27 and B7 indicate that the 
antigenic determinant for TM-1 is located on 
the al-domain of B27 involving amino acid 
residues 77 and 80 (Toubert et al. 1988). 
TM-4 strongly bound to all B 2 7 w + cells, 
except for the subtype B27 K . Also, very few 
(two of 15) H L A - B 4 4 + and B15 + cells were 
stained with this antibody. In 1981 Grumet 
already described a monoclonal antibody, 
B27M1, dividing the B27 antigen into its sub-
types B27 w and B27 K . TM-4 shows a similar 
reactivity with respect to B27 subtypes, but 
the pattern of crossreactivity is different. The 
monoclonal antibody B27M1 crossreacts with 
B47, but not with B44 or B15 (Grumet et al. 
1981). 
Antibody TM-5 reacted with B27 and, to a 
lesser extent, B13, B15 and B37. This binding 
pattern is, except for B15, similar to that of 
the monoclonal antibody BD.7 (Bourel et al. 
1987), supporting evidence of a common epi-
tope on these antigens. 
TM-6 recognized all B27-positive cells, and 
crossreacted with B44 and B15, whereas 
GENERATION OF ANTIBODIES USING B27 TRANSFECTANTS 515 
T M - 5 
0.5 0.25 0.125 0.5 0.25 0.125 0.0625 
Concent ra t ion of C o n c e n t r a t i o n of 
S u p e r n a t a n t S u p e r n a t a n t 
Figure 2. Inhibition of B27 specific cytotoxicity by monoclonal antibodies TM-5, W6/32 and HCIO. 
A: Inhibition of CML by monoclonal antibodies TM-5, W6/32 and HCIO. 
Effector MIWI: HLA-A2, B17, B51, Cwl, Cw6 
Stimulator HASE: HLA-A2, A3, B27w, B37, Cwl 
Target LG-2: HLA-A2, B27w, Cwl 
Effector: target ratio = 15:1 
4000 targets per well 
Dotted horizontal line shows specific lysis without inhibitor (53%). 
B: Inhibition of secondary CML of long term cultured CTL by monoclonal antibody TM-5. 
Effector MIWI: HLA-A2, B17, B51, Cwl, Cw6 stimulated with IL-2 
Stimulator HASE: HLA-A2, A3, B27w, B37, Cwl 
Target LG-2: HLA-A2, B27w, Cwl 
Effector: target ratio = 5:1 
3000 targets per well 
Dotted horizontal line shows specific lysis without inhibitor (40%). 
TM-4 showed some crossreactivity with B8 
and B18 bearing cells and recognized only 
some of these cells, although there are no 
serological splits of these antigens described 
so far (Terasaki 1988). 
Antibody TM-3 bound to all HLA-positive 
cells. The binding-pattern was similar to that 
of W6/32 (Brodsky et ai. 1979, Barnstable et 
al. 1978). Nevertheless, the experiments 
could not distinguish between the recognition 
of a H L A - B specific or a monomorphic H L A -
class I determinant. 
The monoclonal antibodies TM-1, TM-3, 
TM-4 and TM-5 did not show binding to the 
mouse mastocytoma P815, but, as expected, 
strongly reacted to a P815 transfectant ex-
pressing the modified antigen B27.R3 (TM-6 
was not tested on transfectant cells). 
Inhibition of CTL 
Various concentrations of antibody containing 
supernatants were tested for their ability to 
inhibit the lytic activity of B27 specific cyto-
toxic T cells. Antibody TM-5 did inhibit cyto-
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Table 2. 
IgG-class and complement dependent cytotoxicity of 
monoclonal antibodies determined at a 1:10 dilution 
of culture supernatant. Lympholysis was regarded as 
positive if 40% or more of cells were lysed. + and -
indicate positive or negative lympholysis. 
Antibody IgG-class % lysis of target cells 
LEER WLGE 
B8, B27 B13,B44 
FCS 5- 5 -
S43 IgG2a 5 - 5 -
W6/32 IgG2a 95+ 95+ 
ME-1 IgGl 20- 15-
TM-1 IgG2b 95+ 10-
TM-3 IgG2b 95+ 95 + 
TM-4 IgG2b 15- 5-
TM-5 IgG2a 50+ 30-
TM-6 IgM 5 - 5 -
toxicity of the primary response (Figure 2A) , 
whereas W6/32 and HCIO (Stam et al. 1986) 
did not show inhibition as supernatants, al-
though inhibition is described for W6/32 when 
used as diluted ascites fluid (Aparicio et al. 
1985). Inhibition by TM-5 was confirmed in a 
second assay using the same, but long-term 
cultured effector line (Figure 2B). 
Complement dependent cytotoxicity 
Monoclonal antibodies were tested for cyto-
toxicity on B27 + and B27~ P B L (donor 
L E E R : A2, B8, B27 w , Cw2, Cw7; and donor 
W L G E : A2, A3, B13, B44, Cw6) as target 
cells. Most of our undiluted supernatants 
were directly cytotoxic. For this reason, the 
lysis obtained at a 1:10 dilution of antibody 
containing supernatants is shown in Table 2. 
Further dilution of supernatants abrogated 
specific cytotoxicity. Table 2 also shows the 
Ig-isotype of the antibodies as determined by 
immunodiffusion (Ouchterlony 1970). 
Negative controls with F C S , the unrelated 
antibody S43 (IgG2a, Reth et al. 1978) and 
the non-complement fixing antibody ME-1 
(IgGl) (Ellis et al. 1982) lysed 20% or less of 
both target cells, whereas W6/32 (IgG2a) and 
TM-3 (IgG2b) showed strong lysis of the tar-
gets. TM-4 (IgG2b) and TM-6 (IgM) were not 
cytotoxic for these targets, although both anti-
bodies recognized cells expressing the B27 or 
B44 antigen in indirect immunofluorescence. 
Antibodies TM-1 (IgG2b) and TM-5 (IgG2a) 
lysed the heterozygous B 8 + and B27 + cell, but 
failed to lyse the B13 + /B44 + P B L in this assay. 
Discussion 
Most commonly, P B L or Epstein-Barr virus 
transformed B cells are used as immunogens 
to generate monoclonal antibodies against 
H L A antigens. Since these cells present many 
foreign antigens to the mouse, the majority of 
obtained monoclonal antibodies is directed to 
unknown antigens on the B cell. Weak anti-
gens hardly induce any antibody response. 
Murine transfectants carrying single H L A -
genes offer the possibility of reducing the 
number of foreign antigens, especially in a 
syngeneic mouse system, and consequently 
may increase the yield of desired antibodies. 
Margulies et al. (1983) showed that syngeneic 
L-cells expressing a transfected alloantigen 
can induce antibodies specific for the trans-
fected antigens in the serum of most mice. 
Heyes et al. (1986) described the generation 
of specific monoclonal antibodies by immuni-
zation with murine L cells transfected with 
class II antigens. 
In our experiments, the mouse was immu-
nized with a xenogeneic HLA-class I antigen 
on an H-2 compatible background. A 
( B A L B / c x C57BL/6) F i mouse with H2 d / b 
was immunized with a P815 (derived from 
strain DBA/2 with H2 d ) transfectant express-
ing the human MHC-antigen B27. 
All antibodies presented in this paper are 
directed against the HLA-B27 antigen. In in-
direct immunofluorescence assay they all 
crossreact with additional antigens, preferen-
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tially with B44 and B15. One antibody (TM-5) 
also recognizes to some extent B13 and B37, 
another (TM-6) B8 and B18. Antibody TM-4 
did not bind to all cells carrying B44 or B15. 
Maybe it recognizes subtypes of these anti-
gens, which are described elsewhere (Terasaki 
1988). 
Surprisingly, none of the common crossre-
activities to H L A - B 7 , B22 or B47 were ob-
served, although they are described for mono-
clonal antibodies as well as for alloantisera 
(Darke 1983). Initially, we discussed a pos-
sible change of immuno-dominant epitopes by 
the association with murine instead of human 
human ß2-microglobulin. Nevertheless, pres-
ence of co-transfected human ß2-microglobu-
lin did not significantly alter expression of the 
class I antigens on transfectants (preliminary 
observation), although antibodies are avail-
able which differentiate human from murine 
ß2-microglobulin in association with human 
class I antigens. The described TM-antibodies 
bound to transfectants with murine ß2-micro-
globulin as well as to B-cell-lines with human 
ß2-microglobulin. Moreover, different culture 
media supplemented with F C S or pooled hu-
man sera did not influence recognition of 
transfectants by C T L or generation of C T L by 
transfectants (W. Kuon, unpublished obser-
vation). Summing up, it may be said that the 
origin of ß2-microglobulin seems to play a 
minor role in this special system. The muta-
tion from Ser to Arg cannot explain the differ-
ent crossreactivities, as B7 encodes Arg in 
position 131. One monomorphic antibody, 
TM-3, was obtained, which bound to all cells 
expressing H L A (-B) on their surface. 
Antibodies TM-1, TM-3 and TM-5 were 
active in complement dependent microlym-
phocytotoxicity and thus may be useful for 
H L A typing. We observed some discrepancies 
between the reaction pattern when comparing 
the indirect immunofluorescence data with 
complement dependent cytotoxicity results. 
One explanation would be that L C L were 
used for immunofluorescence, which, com-
pared to P B L , expressed an increased amount 
of H L A antigens. 
Moreover, TM-5 could inhibit B27 specifc 
cell mediated lympholysis even at very low 
antibody concentrations (diluted culture su-
pernatant), at which the antibody W6/32 did 
not show inhibition any more. This antibody 
may be helpful to map antigenic epitopes for 
T cells. 
Having obtained these antibodies, we could 
demonstrate that transfectants can induce a 
humoral response in a xenogeneic system and 
may be very useful for the generation of ser-
ological reagents to cell-surface H L A class 
I-antigens. Owing to the mouse background 
of the transfectant cell, induction of antibod-
ies to other human (MHC) antigens present 
on a normal H L A + human B cell can be 
avoided. Although in our case the mutation 
within the B27 gene did not alter the antigenic 
properties of the protein, transfectants may 
also be useful for generating serological re-
agents to genetically modified surface anti-
gens. 
Abbreviations 
C M L Cell mediated lymphocytotoxicity 
C T L Cytotoxic T lymphocyte 
F C S Fetal calf serum 
H L A Human leucocyte antigen 
L C L Lymphoblastoid cell line 
M H C Major histocompatibility complex 
F I T C Fluoresceinisothiocyanate 
P B L Peripheral blood lymphocytes 
PBS Phosphate buffered saline 
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